Symptom Burden Pre Dan Post Operasi Pada Pasien Tumor Buli-Buli: Sebuah Case Report
Abstract
Tumor buli-buli merupakan kondisi patologis pada buli-buli yang dapat menimbulkan berbagai manifestasi klinis, terutama pada sistem urinaria. Pada tumor buli-buli yang bersifat ganas atau kanker buli-buli, pasien dapat mengalami berbagai gejala fisik dan psikologis yang dapat berkontribusi terhadap peningkatan symptom burden, yang selanjutnya berpotensi memengaruhi fungsi fisik, kualitas hidup, dan persepsi pasien terhadap kondisi kesehatannya. Tujuan penelitian ini yakni memberikan gambaran terkait symptom burden pre dan post operasi pada pasien tumor buli-buli yang menjalani Transurethral Resection of Bladder Tumor (TURBT). Penelitian ini menerapkan metode case report dengan pendekatan deskriptif yang dilakukan pada seorang pasien laki-laki berusia 62 tahun. Hasil penelitian menunjukkan bahwa pada fase preoperasi, pasien dengan tumor buli-buli memiliki skor relatif tinggi secara numerik pada beberapa domain ESAS-r, terutama nyeri, kelelahan, kecemasan, kesedihan, dan persepsi kesehatan secara keseluruhan. Setelah tindakan TURBT, beberapa domain gejala mengalami penurunan skor, sedangkan sesak napas, kesedihan, persepsi kesehatan secara keseluruhan, dan masalah lain yang dirasakan pasien tetap pada skor yang sama. Perubahan skor tersebut menggambarkan adanya perubahan kondisi dan gejala pasien selama periode perawatan, tetapi tidak dapat diinterpretasikan sebagai efek langsung TURBT karena pasien juga mendapatkan berbagai terapi dan mengalami perubahan kondisi klinis selama periode pengkajian.
Kata Kunci: edmonton symptom assessment system-revised, symptom burden,tumor buli-buli
Full Text:
PDFReferences
Babjuk, M., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Escrig, J. L. D., Gontero, P., Liedberg, F., Masson, A., Mostafid, A. H., Palou, J., Rhijn, B. W. G. Van, & Rouprêt, M. (2022). European Association of Urology Guidelines on Non-muscleinvasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). European Urology, 81(1), 75–94. DOI:https://doi.org/10.1016/j.eururo.2021.08.010
Bjurlin, M. A., Matulewicz, R. S., Roberts, T. R., Dearing, B. A., Schatz, D., Sherman, S., Gordon, T., & Shahawy, O. El. (2021). Carcinogen Biomarkers in the Urine of Electronic Cigarette Users and Implications for the Development of Bladder Cancer: A Systematic Review. European Urology Oncology, 4(5), 766–783. DOI:https://doi.org/10.1016/j.euo.2020.02.004
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2019). Iron Deficiency Anaemia Revisited. Journal of Internal Medicine, 287(2), 153–170. DOI: https://doi.org/10.1111/joim.13004
Catto, J. W. F., Gordon, K., Collinson, M., Poad, ; Heather, Twiddy, M., Johnson, M., Sunjay Jain, ;Chahal, R., Simms, M., Dooldeniya, M., Bell, ; Richard, Koenig, P., Conroy, S., Goodwin, L., Noon, A. P., Croft, ; Julie, & Brown, J. M. (2020). Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study. J Clin Oncol, 39, 202–214. DOI:https://doi.org/10.1200/JCO.20
Comperat, E., Amin, M. B., Berney, D. M., Cree, I., Menon, S., Moch, H., Netto, G. J., Rao, V., Raspollini, M. R., Mark A Rubin, 13 John R Srigley, 14 Puay Hoon Tan, 15 Satish Kumar Tickoo, 16, & Tsuzuki18, S. T. & T. (2022). What’s New in WHO Fifth Edition – Urinary Tract. Histopathology, 81, 439–446. DOI:https://doi.org/10.1111/his.14764
Degeorge, K. C., Holt, H. R., & Hodges, S. C. (2017). Bladder Cancer: Diagnosis and Treatment. American Family Physician, 96(8), 507–514.
Fadhil, F., Alvarino, A., & Akhyar, G. (2024). Hubungan Stadium Kanker dan Jenis Terapi yang diberikan Dengan Tingkat Kualitas Hidup Penderita Kanker Buli-Buli di RSUP Dr. M. Djamil Padang Tahun 2018–2021 Fikri. Jurnal Inovasi Riset Ilmu Kesehatan, 2(3), 33–47. DOI: https://doi.org/10.55606/detector.v2i3.4012
Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I. (2018). Management of Cancer Pain in Adult Patients : ESMO Clinical Practice Guidelines. Annals of Oncology, 29(Supplement 4), iv166–iv191. DOI:https://doi.org/10.1093/annonc/mdy152
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., Stovall, E. L., Zimmermann, C., & Smith, T. J. (2017). Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology, 35(1),96–112. DOI:https://doi.org/10.1200/JCO.2016.70.1474
Hausner, D., Tricou, C., Mathews, J., Wadhwa, D., Pope, A., & Swami, N. (2021). Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative Care. The Oncologist, 26(4), 332–340. DOI:https://doi.org/10.1002/onco.13625
Ke, Q.-S., Lee, C.-L., & Kuo, H.-C. (2021). Recurrent Urinary Tract Infection in Women and Overactive Bladder - Is There a Relationship? Tzu Chi Medical Journal, 33(1), 13–21. DOI:https://doi.org/10.4103/tcmj.tcmj
Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A., & Suppe, F. (1997). The Middle-Range Theory of Unpleasant Symptoms: An Update. Advances in Nursing Science, 19(3), 14–27. DOI:https://doi.org/10.1097/00012272-199703000-00003
Leslie, S. W., Soon-Sutton, T. L., & Aeddula., N. R. (2024). Bladder Cancer. StatPearls Publishing. Retrieved from:https://www.ncbi.nlm.nih.gov/books/NBK536923/
Pitman, A., Consultant, M., Psychiatrist, L., & Clinical, S. (2018). Depression and Anxiety in Patients with Cancer. BMJ, 361,k1415. DOI:https://doi.org/10.1136/bmj.k1415
• Puente, J., Rodríguez, A., Elena, V., Sergio, S., Estévez, V., Álvarez, C., Chirivella, I., Ángel, M., Ovidio, C., Alfonso, F., Liaño, G. De, & Valderrama, B. P. (2025). SEOM-SOGUG Clinical Guideline for Urothelial Cancer (2025). Clinical and Translational Oncology, 27(11), 4142–4159. DOI: 10.1007/s12094-025-04045-2.
Richters, A., Aben, K. K. H., & Kiemeney, L. A. L. M. (2020). The Global Burden of Urinary Bladder Cancer: an Update. World Journal of Urology, 38(8), 1895–1904. DOI:https://doi.org/10.1007/s00345-019-02984-4
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. DOI:https://doi.org/10.3322/caac.21660
Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2021). Advances in Bladder Cancer Biology and Therapy. Nature Reviews Cancer, 21(2), 104–121. DOI:https://doi.org/10.1038/s41568-020-00313-1
Watanabe, S. M., Nekolaichuk, C., Beaumont, C., Johnson, L., Myers, J., & Strasser, F. (2011). A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients. Journal of Pain and Symptom Management, 41(2), 456–468. DOI:https://doi.org/10.1016/j.jpainsymman.2010.04.020
DOI: https://doi.org/10.37638/jsk.33.2.129-141
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Nia Alviani, Hesti Platini
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
JURNAL SAINS KESEHATAN indexed by:
_1.png)
Lembaga Penelitian dan Pengabdian Masyarakat (LPPM)
STIKES Tri Mandiri Sakti Bengkulu
Mail : Jalan Raya Hibrida No. 3, Sido Mulyo, Gading Cempaka, Sido Mulyo, Bengkulu, Kota Bengkulu, Bengkulu 38229Telp :(0736) 25091 Fax (0736) 23703
email: jsk@stikestrimandirisakti.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License